Chimerix (CMRX) News Today $8.54 0.00 (0.00%) As of 04/21/2025 Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Chimerix (NASDAQ:CMRX) Research Coverage Started at StockNews.comMay 5 at 2:25 AM | americanbankingnews.comWhy Chimerix Inc. (CMRX) is Surging in 2025April 30, 2025 | msn.comRenaissance Technologies LLC Sells 518,941 Shares of Chimerix, Inc. (NASDAQ:CMRX)Renaissance Technologies LLC lowered its holdings in Chimerix, Inc. (NASDAQ:CMRX - Free Report) by 38.7% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 820,349 shares of the biopharmaceutical company's stoApril 27, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Coverage Initiated by Analysts at StockNews.comStockNews.com assumed coverage on Chimerix in a research report on Thursday. They set a "sell" rating on the stock.April 26, 2025 | marketbeat.comMarshall Wace LLP Has $7.71 Million Position in Chimerix, Inc. (NASDAQ:CMRX)Marshall Wace LLP boosted its holdings in Chimerix, Inc. (NASDAQ:CMRX - Free Report) by 1,318.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,213,940 shares of the biopharmaceutical company's stock after purchasApril 25, 2025 | marketbeat.com391,274 Shares in Chimerix, Inc. (NASDAQ:CMRX) Acquired by Walleye Capital LLCWalleye Capital LLC bought a new stake in shares of Chimerix, Inc. (NASDAQ:CMRX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 391,274 shares of the biopharmaceutical company's stock, valued at approximatelyApril 22, 2025 | marketbeat.comEAM Investors LLC Takes $786,000 Position in Chimerix, Inc. (NASDAQ:CMRX)EAM Investors LLC acquired a new position in shares of Chimerix, Inc. (NASDAQ:CMRX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 225,777 shares of the biopharmaceutical company's stock, valApril 19, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Sets New 52-Week High - Time to Buy?Chimerix (NASDAQ:CMRX) Hits New 12-Month High - What's Next?April 17, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Now Covered by StockNews.comStockNews.com initiated coverage on Chimerix in a research report on Wednesday. They set a "hold" rating for the company.April 17, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Sets New 52-Week High - Should You Buy?Chimerix (NASDAQ:CMRX) Reaches New 12-Month High - Here's WhyApril 10, 2025 | marketbeat.comJAZZ Pharmaceuticals Stock Trades Near 52-Week Low: Time to Buy or Sell?April 9, 2025 | msn.comChimerix, Inc. (NASDAQ:CMRX) Shares Sold by ADAR1 Capital Management LLCADAR1 Capital Management LLC decreased its holdings in shares of Chimerix, Inc. (NASDAQ:CMRX - Free Report) by 49.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 122,236 shares of the biopharmaceutical company's stock afApril 9, 2025 | marketbeat.comStockNews.com Initiates Coverage on Chimerix (NASDAQ:CMRX)StockNews.com began coverage on shares of Chimerix in a research report on Tuesday. They set a "hold" rating for the company.April 9, 2025 | marketbeat.comChimerix, Inc. (NASDAQ:CMRX) Shares Sold by Yakira Capital Management Inc.Yakira Capital Management Inc. reduced its holdings in shares of Chimerix, Inc. (NASDAQ:CMRX - Free Report) by 79.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 103,489 shares of the biopharmaceutical companyApril 8, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Reaches New 52-Week High - Time to Buy?Chimerix (NASDAQ:CMRX) Sets New 12-Month High - Time to Buy?April 4, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Makes New $183,000 Investment in Chimerix, Inc. (NASDAQ:CMRX)Charles Schwab Investment Management Inc. purchased a new position in Chimerix, Inc. (NASDAQ:CMRX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 52,657 shares of the biopharmaceutical coApril 3, 2025 | marketbeat.comIs Chimerix Inc. (CMRX) the Best Performing NASDAQ Stock So Far in 2025?April 2, 2025 | msn.comChimerix, Inc. (NASDAQ:CMRX) Sees Significant Drop in Short InterestChimerix, Inc. (NASDAQ:CMRX - Get Free Report) saw a large decrease in short interest in the month of March. As of March 15th, there was short interest totalling 3,410,000 shares, a decrease of 27.9% from the February 28th total of 4,730,000 shares. Based on an average daily volume of 3,850,000 shares, the days-to-cover ratio is currently 0.9 days. Approximately 4.3% of the company's shares are sold short.March 31, 2025 | marketbeat.comStockNews.com Begins Coverage on Chimerix (NASDAQ:CMRX)StockNews.com started coverage on shares of Chimerix in a research note on Monday. They issued a "hold" rating for the company.March 31, 2025 | marketbeat.comChimerix Inc. (NASDAQ:CMRX) Amazing Performance So Far In 2025March 26, 2025 | msn.comRosalind Advisors Inc. Invests $10.61 Million in Chimerix, Inc. (NASDAQ:CMRX)Rosalind Advisors Inc. purchased a new stake in Chimerix, Inc. (NASDAQ:CMRX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 3,050,000 shares of the biopharmaceutical company's stock, valued at approximately $10,614,000. ChimMarch 23, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Releases Earnings Results, Beats Estimates By $0.01 EPSChimerix (NASDAQ:CMRX - Get Free Report) released its earnings results on Friday. The biopharmaceutical company reported ($0.25) earnings per share for the quarter, topping the consensus estimate of ($0.26) by $0.01. The business had revenue of $0.06 million for the quarter, compared to the consensus estimate of $0.31 million.March 22, 2025 | marketbeat.comChimerix reports Q4 EPS (25c), consensus (28c)March 22, 2025 | markets.businessinsider.comChimerix Reports Fourth Quarter and Year End 2024 Financial ResultsMarch 21, 2025 | globenewswire.comConnor Clark & Lunn Investment Management Ltd. Acquires 84,801 Shares of Chimerix, Inc. (NASDAQ:CMRX)Connor Clark & Lunn Investment Management Ltd. increased its stake in Chimerix, Inc. (NASDAQ:CMRX - Free Report) by 24.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 429,513 shares ofMarch 20, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Hits New 52-Week High - Should You Buy?Chimerix (NASDAQ:CMRX) Sets New 52-Week High - Time to Buy?March 18, 2025 | marketbeat.comChimerix, Inc. (NASDAQ:CMRX) Holdings Reduced by Monaco Asset Management SAMMonaco Asset Management SAM trimmed its position in Chimerix, Inc. (NASDAQ:CMRX - Free Report) by 33.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 2,820,792 shares of the biopharmaceutical company's stock after selliMarch 15, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Earns Hold Rating from Analysts at StockNews.comStockNews.com assumed coverage on shares of Chimerix in a research note on Saturday. They issued a "hold" rating on the stock.March 15, 2025 | marketbeat.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDFN, BLBX, CMRX, WBA on Behalf of ShareholdersMarch 14, 2025 | morningstar.comChimerix (NASDAQ:CMRX) Sets New 12-Month High - Here's What HappenedChimerix (NASDAQ:CMRX) Hits New 12-Month High - Here's WhyMarch 13, 2025 | marketbeat.comCHIMERIX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Chimerix, Inc. - CMRXMarch 10, 2025 | businesswire.comChimerix (NASDAQ:CMRX) Sees Strong Trading Volume - Should You Buy?Chimerix (NASDAQ:CMRX) Sees Strong Trading Volume - Time to Buy?March 8, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Upgraded at Jones TradingJones Trading upgraded shares of Chimerix to a "hold" rating in a report on Thursday.March 8, 2025 | marketbeat.comCMRX Stock Surges on JAZZ Acquisition BidMarch 8, 2025 | finance.yahoo.comCMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. ...March 7, 2025 | gurufocus.comChimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 7, 2025 | globenewswire.comCMRX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Chimerix, Inc. is Fair to ShareholdersMarch 7, 2025 | globenewswire.comJefferies Financial Group Reaffirms "Hold" Rating for Chimerix (NASDAQ:CMRX)Jefferies Financial Group reissued a "hold" rating and issued a $8.50 target price (down from $10.00) on shares of Chimerix in a research report on Wednesday.March 6, 2025 | marketbeat.comPromising Small Cap Stocks To Follow Now - March 5thChimerix, AltC Acquisition, Visionary, Visionary, and Gorilla Technology Group are the five Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small cap stocks are shares of companies with relatively small market capitalizations, generally ranging from around US$300 milMarch 6, 2025 | marketbeat.comChimerix downgraded to Hold from Buy at JonesResearchMarch 6, 2025 | markets.businessinsider.comWedbush Reiterates Neutral Rating for Chimerix (NASDAQ:CMRX)Wedbush restated a "neutral" rating and set a $8.55 target price (up from $7.00) on shares of Chimerix in a research report on Wednesday.March 6, 2025 | marketbeat.comChimerix's (CMRX) Neutral Rating Reaffirmed at HC WainwrightHC Wainwright restated a "neutral" rating and set a $8.55 price target (down previously from $11.00) on shares of Chimerix in a research note on Wednesday.March 6, 2025 | marketbeat.comChimerix (NASDAQ:CMRX) Shares Gap Up - Time to Buy?Chimerix (NASDAQ:CMRX) Shares Gap Up - Should You Buy?March 6, 2025 | marketbeat.comChimerix downgraded to Neutral from Outperform at WedbushMarch 6, 2025 | markets.businessinsider.comChimerix (NASDAQ:CMRX) Hits New 12-Month High - What's Next?Chimerix (NASDAQ:CMRX) Reaches New 12-Month High - Time to Buy?March 6, 2025 | marketbeat.comNorth Carolina drugmaker sold in $935M dealMarch 6, 2025 | bizjournals.comCMRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Chimerix, Inc. Is Fair to ShareholdersMarch 6, 2025 | tmcnet.comChimerix downgraded to Neutral from Buy at H.C. WainwrightMarch 6, 2025 | markets.businessinsider.comChimerix downgraded to Hold from Buy at JefferiesMarch 6, 2025 | msn.comHC Wainwright & Co. Downgrades Chimerix (CMRX)March 6, 2025 | msn.com Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address CMRX Media Mentions By Week CMRX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CMRX News Sentiment▼0.000.69▲Average Medical News Sentiment CMRX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CMRX Articles This Week▼23▲CMRX Articles Average Week Get Chimerix News Delivered to You Automatically Sign up to receive the latest news and ratings for CMRX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Crinetics Pharmaceuticals News Today Scholar Rock News Today Merus News Today Catalyst Pharmaceuticals News Today Xenon Pharmaceuticals News Today MorphoSys News Today Protagonist Therapeutics News Today MoonLake Immunotherapeutics News Today HUTCHMED News Today Immunovant News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CMRX) was last updated on 5/6/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump’s Bitcoin Reserve is No Accident…Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...Crypto 101 Media | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chimerix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Chimerix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CMRX Stock Free CMRX Stock Alerts